BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

523 related articles for article (PubMed ID: 1931574)

  • 1. The pathogenic role of growth factors in melanoma.
    Richmond A
    Semin Dermatol; 1991 Sep; 10(3):246-55. PubMed ID: 1931574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor progression in the human melanocytic system.
    Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
    Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the role of melanoma growth stimulatory activity (MGSA) in the growth of normal melanocytes, nevocytes, and malignant melanocytes.
    Bordoni R; Fine R; Murray D; Richmond A
    J Cell Biochem; 1990 Dec; 44(4):207-19. PubMed ID: 2095366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma growth stimulatory activity in primary malignant melanoma: prognostic significance.
    Middleman BR; Friedman M; Lawson DH; DeRose PB; Cohen C
    Mod Pathol; 2002 May; 15(5):532-7. PubMed ID: 12011258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma growth stimulatory activity: isolation from human melanoma tumors and characterization of tissue distribution.
    Richmond A; Thomas HG
    J Cell Biochem; 1988 Feb; 36(2):185-98. PubMed ID: 3356754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biology of tumor progression in human melanocytes.
    Herlyn M; Clark WH; Rodeck U; Mancianti ML; Jambrosic J; Koprowski H
    Lab Invest; 1987 May; 56(5):461-74. PubMed ID: 3553733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.
    Schadendorf D; Möller A; Algermissen B; Worm M; Sticherling M; Czarnetzki BM
    J Immunol; 1993 Sep; 151(5):2667-75. PubMed ID: 8360485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autocrine and paracrine roles for growth factors in melanoma.
    Shih IM; Herlyn M
    In Vivo; 1994; 8(1):113-23. PubMed ID: 7519892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of cultured human melanocytes isolated from different stages of tumor progression.
    Herlyn M; Thurin J; Balaban G; Bennicelli JL; Herlyn D; Elder DE; Bondi E; Guerry D; Nowell P; Clark WH
    Cancer Res; 1985 Nov; 45(11 Pt 2):5670-6. PubMed ID: 4053039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
    Lázár-Molnár E; Hegyesi H; Tóth S; Falus A
    Cytokine; 2000 Jun; 12(6):547-54. PubMed ID: 10843728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
    Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
    Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of thyrotropin-releasing hormone by human melanoma and nevi.
    Ellerhorst JA; Naderi AA; Johnson MK; Pelletier P; Prieto VG; Diwan AH; Johnson MM; Gunn DC; Yekell S; Grimm EA
    Clin Cancer Res; 2004 Aug; 10(16):5531-6. PubMed ID: 15328193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor progression in melanoma: the biology of epidermal melanocytes in vitro.
    Mancianti ML; Herlyn M
    Carcinog Compr Surv; 1989; 11():369-86. PubMed ID: 2646021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular markers of melanocytic tumor progression.
    Weterman MA; van Muijen GN; Bloemers HP; Ruiter DJ
    Lab Invest; 1994 May; 70(5):593-608. PubMed ID: 8196357
    [No Abstract]   [Full Text] [Related]  

  • 15. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
    Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
    Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of cytokines belonging to the interleukin-8 family by human gingival fibroblasts stimulated with interleukin-1 beta in culture.
    Odake H; Koizumi F; Hatakeyama S; Furuta I; Nakagawa H
    Exp Mol Pathol; 1993 Feb; 58(1):14-24. PubMed ID: 8454034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
    Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
    Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of AP-2alpha, c-kit, and cleaved caspase-6 and -3 in naevi and malignant melanomas of the skin. A possible role for caspases in melanoma progression?
    Woenckhaus C; Giebel J; Failing K; Fenic I; Dittberner T; Poetsch M
    J Pathol; 2003 Oct; 201(2):278-87. PubMed ID: 14517845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
    Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
    Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of autostimulatory and transforming growth factors from human melanoma cells.
    Richmond A; Lawson DH; Nixon DW; Chawla RK
    Cancer Res; 1985 Dec; 45(12 Pt 1):6390-4. PubMed ID: 3864531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.